Literature DB >> 21472119

Clinical significance of occult hepatitis B virus infection.

Miriam Romero1, Antonio Madejón, Conrado Fernández-Rodríguez, Javier García-Samaniego.   

Abstract

Occult hepatitis B virus (HBV) infection (OBI) is defined as the presence of HBV DNA in the liver (with or without detectable HBV DNA in serum) for individuals testing HBV surface antigen negative. Until recently, the clinical effect of OBI was unclear on the progression of liver disease; on the development of hepatocellular carcinoma; and on the risk for reactivation or transmission of HBV infection. Several studies suggest a high prevalence of OBI among patients with cryptogenic chronic liver disease, but its role in the progression to cirrhosis remains unclear. Although OBI has been well documented in human immunodeficiency virus (HIV)-positive patients, especially among those coinfected with hepatitis C virus, further studies are needed to determine its current clinical impact in HIV setting.

Entities:  

Keywords:  Cryptogenic cirrosis; Hepatitis B virus coinfection; Human immunodeficiency virus; Liver disease; Occult hepatitis B virus infection

Mesh:

Substances:

Year:  2011        PMID: 21472119      PMCID: PMC3070124          DOI: 10.3748/wjg.v17.i12.1549

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  22 in total

1.  A European perspective on the management of donors and units testing positive for hepatitis B virus DNA.

Authors:  Jean-Pierre Allain; Henk W Reesink; Charles Lucey
Journal:  Transfusion       Date:  2006-07       Impact factor: 3.157

2.  Occult hepatitis B virus infection and cryptogenic chronic hepatitis in an area with intermediate prevalence of HBV infection.

Authors:  Mohammad Javad Kaviani; Behzad Behbahani; Mohammad Jafar Mosallaii; Fatemeh Sari-Aslani; Seyed Alireza Taghavi
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

3.  Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy.

Authors:  Chee-Kin Hui; Winnie W W Cheung; Hai-Ying Zhang; Wing-Yan Au; Yui-Hung Yueng; Anskar Y H Leung; Nancy Leung; John M Luk; Albert K W Lie; Yok-Lam Kwong; Raymond Liang; George K K Lau
Journal:  Gastroenterology       Date:  2006-07       Impact factor: 22.682

4.  Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection.

Authors:  Henry Lik-Yuen Chan; Steven Woon-Choi Tsang; Nancy Wai-Yee Leung; Chi-Hang Tse; Yui Hui; John Siu-Lun Tam; Francis Ka-Leung Chan; Joseph Jao-Yiu Sung
Journal:  Am J Gastroenterol       Date:  2002-05       Impact factor: 10.864

Review 5.  A 2010 update on occult hepatitis B infection.

Authors:  G Raimondo; T Pollicino; L Romanò; A R Zanetti
Journal:  Pathol Biol (Paris)       Date:  2010-03-19

6.  The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.

Authors:  Alessandro Zerbini; Massimo Pilli; Carolina Boni; Paola Fisicaro; Amalia Penna; Paola Di Vincenzo; Tiziana Giuberti; Alessandra Orlandini; Giuseppina Raffa; Teresa Pollicino; Giovanni Raimondo; Carlo Ferrari; Gabriele Missale
Journal:  Gastroenterology       Date:  2008-02-14       Impact factor: 22.682

7.  Occult hepatitis B virus infection in immunocompromised patients.

Authors:  Ruth Nogueira Cordeiro Moraes Jardim; Neiva Sellan Lopes Gonçales; Josiane Silveira Felix Pereira; Viviane Cristina Fais; Fernando Lopes Gonçales Junior
Journal:  Braz J Infect Dis       Date:  2008-08       Impact factor: 1.949

Review 8.  The implications of antiviral drugs with activity against hepatitis B virus and HIV.

Authors:  Marcelle Bottecchia; Javier Garcia-Samaniego; Vincent Soriano
Journal:  Curr Opin Infect Dis       Date:  2007-12       Impact factor: 4.915

9.  Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.

Authors:  Masahiro Satake; Rikizo Taira; Hisao Yugi; Satoru Hino; Kimihiro Kanemitsu; Hisami Ikeda; Kenji Tadokoro
Journal:  Transfusion       Date:  2007-07       Impact factor: 3.157

10.  Occult hepatitis B virus in liver tissue of individuals without hepatic disease.

Authors:  Giovanni Raimondo; Giuseppe Navarra; Stefania Mondello; Lucy Costantino; Guido Colloredo; Eugenio Cucinotta; Gaetano Di Vita; Claudio Scisca; Giovanni Squadrito; Teresa Pollicino
Journal:  J Hepatol       Date:  2008-02-13       Impact factor: 25.083

View more
  8 in total

1.  Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt.

Authors:  Abeer Elkady; Sahar Aboulfotuh; Elsayed Mostafa Ali; Douaa Sayed; Nashwa M Abdel-Aziz; Amany M Ali; Shuko Murakami; Sayuki Iijima; Yasuhito Tanaka
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

Review 2.  Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc Testing.

Authors:  Antonella Esposito; Chiara Sabia; Carmela Iannone; Giovanni F Nicoletti; Linda Sommese; Claudio Napoli
Journal:  Transfus Med Hemother       Date:  2017-05-05       Impact factor: 3.747

3.  Occult hepatitis B virus infection: a complex entity with relevant clinical implications.

Authors:  Juan-Ramon Larrubia
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

4.  Hepatitis B surface gene variants isolated from blood donors with overt and occult HBV infection in north eastern Egypt.

Authors:  Rania Kishk; Nader Nemr; Abeer Elkady; Mohamed Mandour; Mohamed Aboelmagd; Nevene Ramsis; Mohamed Hassan; Nashaat Soliman; Sayuki Iijima; Shuko Murakami; Yasuhito Tanaka; Mostafa Ragheb
Journal:  Virol J       Date:  2015-09-30       Impact factor: 4.099

5.  Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation.

Authors:  Amadin A Olotu; Adesola O Oyelese; Lateef Salawu; Rosemary A Audu; Azuka P Okwuraiwe; Aaron O Aboderin
Journal:  Virol J       Date:  2016-05-05       Impact factor: 4.099

6.  Characterization of the occult hepatitis B virus variants circulating among the blood donors from eastern India.

Authors:  Avik Biswas; Rajesh Panigrahi; Partha Kumar Chandra; Arup Banerjee; Sibnarayan Datta; Manisha Pal; Subhashish Chakraborty; Prasun Bhattacharya; Sekhar Chakrabarti; Runu Chakravarty
Journal:  ScientificWorldJournal       Date:  2013-11-04

7.  High prevalence of occult hepatitis B virus genotype H infection among children with clinical hepatitis in west Mexico.

Authors:  Griselda Escobedo-Melendez; Arturo Panduro; Nora A Fierro; Sonia Roman
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-08-05       Impact factor: 2.743

8.  The correlation between renal transplantation and liver carcinoma: a meta-analysis.

Authors:  Hong Yongzhi; Xu Min; Yu Bo; Chen Pin; Shi Xueqiang
Journal:  Oncotarget       Date:  2017-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.